<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01644942</url>
  </required_header>
  <id_info>
    <org_study_id>8193</org_study_id>
    <nct_id>NCT01644942</nct_id>
  </id_info>
  <brief_title>Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation</brief_title>
  <official_title>Identification in Obese Patients of the Mechanisms Involved in Intramuscular Lipid Accumulation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine in obese patients the implication of intramuscular lipid
      accumulation in relation with insulin resistance and defect in lipid oxidation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese insulin sensitive and obese insulin resistant patients undergo a glucose tolerance
      test, indirect calorimetry during exercise and muscular biopsy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lipid accumulation in skeletal muscle</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>lipid accumulation in myotubes from obese patients</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>Insulin sensitive patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin resistant patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lipid accumulation analysis</intervention_name>
    <description>The lipid accumulation will be assessed with muscular biopsies.</description>
    <arm_group_label>Insulin sensitive patients</arm_group_label>
    <arm_group_label>Insulin resistant patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese patients with a Body Mass Index (BMI) between 30 and 40 kg/m2

          -  Patients who do not practice physical exercise (Voorips index &lt; 9)

          -  Age between 40 and 70 years- Male gender

          -  Fast blood glucose &lt;1,10 g/l and no hypoglycemic treatment

          -  Signed informed consent

          -  Social security affiliation

          -  Absence of anti VIH, anti hepatitis C antibodies, and HBS antigen

          -  Normal biological tests

          -  Non smoking persons

        Exclusion Criteria:

          -  Patients who refuse the anti-VIH, anti-hepatitis C antibodies, and HBS antigens tests

          -  Patients treated by anticoagulant, b blockers, lipopenic, or anti-inflammatory.

          -  Patients with a contraindication to muscular exercise (retinopathy, coronaropathy,
             nephropathy) and to muscular biopsy

          -  Allergy to local anaesthetic
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHRU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2012</study_first_posted>
  <last_update_submitted>June 17, 2013</last_update_submitted>
  <last_update_submitted_qc>June 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obese</keyword>
  <keyword>insulin sensitive</keyword>
  <keyword>insulin resistant</keyword>
  <keyword>myotubes</keyword>
  <keyword>lipid accumulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

